LOCALLY ADVANCED SARCOMA

Clinical trials for LOCALLY ADVANCED SARCOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED SARCOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial targets specific genetic flaws in Tough-to-Treat cancers

Disease control Ongoing

This study is testing an oral drug called rogaratinib for adults with advanced sarcoma or a rare stomach tumor called SDH-deficient GIST. The drug aims to block specific proteins that help these cancer cells grow, with the goal of shrinking tumors and controlling the disease. It …

Matched conditions: LOCALLY ADVANCED SARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

LOCALLY ADVANCED SARCOMA

Get alerted when new LOCALLY ADVANCED SARCOMA trials appear

New drug trial targets specific genetic flaws in Tough-to-Treat cancers